touchPODCAST

touchMDT for touchONCOLOGY Listen to key experts from a multidisciplinary team discuss the tools used to predict response to immunotherapy, and they review emerging biomarkers. The multidisciplinary team: Pathologist: Prof. Albrecht Stenzinger, University Hospital Heidelberg, Heidelberg, Germany Medical Oncologist: Prof. Raffaele Califano, The Christie and Manchester University Hospital, Mancheste...

touchMDT for touchONCOLOGY Listen to key experts from a multidisciplinary team, plus a survivor of metastatic NSCLC, discuss the importance of involving patients in their treatment decisions and how clinicians can best support patients throughout their treatment journey. The multidisciplinary team: Medical Oncologist: Prof. Raffaele Califano, The Christie and Manchester University Hospital, Manche...

touchMDT for touchONCOLOGY Listen to key experts from a multidisciplinary team discuss the challenges associated with standard-of-care immunotherapy for metastatic NSCLC without driver mutations, including treatment resistance and toxicity. The multidisciplinary team: Medical Oncologist: Prof. Raffaele Califano, The Christie and Manchester University Hospital, Manchester, UK Oncology Pharmacist: P...

touchPANEL DISCUSSION for touchHAEMATOLOGY Listen to a panel of leading experts discuss the burden and clinical presentation of pyruvate kinase (PK) deficiency, the current treatment strategies and remaining unmet treatment need, and future approaches to managing the disease.  The experts: Dr Rachael Grace, Dana-Farber/Boston Children’s Cancer and Blood Disorders Center and Harvard Medical School,...

touchPANEL DISCUSSION for touchENDOCRINOLOGY Listen to a radiologist, a nephrologist and a primary care physician discuss how to predict progression and prognosis in ADPKD, as well as current and emerging treatment options for rapidly progressing disease, and how to manage potential side effects.  The experts: Prof. Bradley Erickson, Mayo Clinic College of Medicine and Science, Rochester, MN, USA;...

touchPANEL DISCUSSION for touchONCOLOGY  Listen to a panel of leading experts discuss the burden and clinical presentation of pyruvate kinase (PK) deficiency, the current treatment strategies and remaining unmet treatment need, and future approaches to managing the disease.  The experts Dr Rachael Grace, Dana-Farber/Boston Children’s Cancer and Blood Disorders Center and Harvard Medical School, Bo...

touchMDT for touchNEUROLOGY Listen to key experts from a multidisciplinary team, plus a patient advocate who is the parent of a patient with DMD, discuss the traditional and non-traditional signs and symptoms of the condition. The multidisciplinary team: Paediatrician: Dr Laura Kauffman, Weissbluth Pediatrics, Chicago, IL, USA Neurologist: Prof. Nancy Kuntz, Northwestern University Feinberg School...

touchMDT for touchNEUROLOGY Listen to key experts from a multidisciplinary team, plus a patient advocate who is the parent of a patient with DMD, discuss the key considerations for the diagnosis of DMD and pre-symptomatic screening for the condition. The multidisciplinary team: Neurologist: Prof. Nancy Kuntz, Northwestern University Feinberg School of Medicine, Chicago, IL, USA Geneticist: Dr Nadi...

touchMDT for touchNEUROLOGY Listen to key experts from a multidisciplinary team discuss established treatments and the importance of the multidisciplinary team in the management of DMD. The multidisciplinary team: Paediatrician: Dr Laura Kauffman, Weissbluth Pediatrics, Chicago, IL, USA Geneticist: Dr Nadia Merchant, Children’s National Hospital, Washington, DC, USA Neurologist: Prof. Nancy Kuntz,...

touchMDT for touchNEUROLOGY Listen to key experts from a multidisciplinary team discuss novel pharmacological and gene therapies that are available or emerging for the management of DMD. The multidisciplinary team: Neurologist: Prof. Nancy Kuntz, Northwestern University Feinberg School of Medicine, Chicago, IL, USA Geneticist: Dr Nadia Merchant, Children’s National Hospital, Washington, DC, USA Th...

touchTALKS for touchNEUROLOGY Listen to a leading expert in the management of patients with multiple sclerosis review the cellular model of disease, and how disease pathophysiology can offer novel therapeutic targets. Prof. Derfuss outlines the role of immune cells in driving multiple sclerosis pathogenesis, explains how the pathobiology of the disease has driven the development of disease-modifyi...

touchTALKS for touchIMMUNOLOGY Listen to a leading expert in the management of patients with multiple sclerosis review the cellular model of disease, and how disease pathophysiology can offer novel therapeutic targets. Prof. Derfuss outlines the role of immune cells in driving multiple sclerosis pathogenesis, explains how the pathobiology of the disease has driven the development of disease-modify...

touchTALKS for touchONCOLOLOGY Listen to a leading expert discussing the recent developments in esophageal cancer with a primary focus on esophageal squamous cell carcinoma (ESCC)  The expert: Dr Elizabeth Smyth, Addenbrooke’s Hospital, Cambridge, UK Overview: Part 1: Insights from 2021 (0:00) Part 2: Insights from ASCO and ESMO GI 2022 (13:29) Part 3: Insights from the updated ESMO Clinical Pract...

touchEXPERT OPINIONS for touchENDOCRINOLOGY Listen to a leading expert sharing insights on the natural history and prevalence of alpha-mannosidosis, how to establish diagnosis, and the current and emerging treatment options for patients with this lysosomal storage disorder.  The expert: Prof. Barbara K Burton, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA This touchPODCAST...

touchEXPERT OPINIONS for touchRESPIRATORY Listen to a leading expert sharing insights on the natural history and prevalence of alpha-mannosidosis, how to establish diagnosis, and the current and emerging treatment options for patients with this lysosomal storage disorder.  The expert: Prof. Barbara K Burton, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA This touchPODCAST i...

touchEXPERT OPINIONS for touchNEUROLOGY Listen to a leading expert sharing insights on the natural history and prevalence of alpha-mannosidosis, how to establish diagnosis, and the current and emerging treatment options for patients with this lysosomal storage disorder.  The expert: Prof. Barbara K Burton, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA This touchPODCAST is...

touchMDT for touchONCOLOGY  A medical oncologist and a pathologist discuss HER2 testing in patients with colorectal cancer, including when and how to test, and the interpretation of test results. The multidisciplinary team: Medical oncologist: Prof. Andrea Sartore-Bianchi, Niguarda Cancer Center, Milan, Italy Pathologist: Dr Evgeny Yakirevich, Rhode Island Hospital, Providence, RI, USA This touchP...

touchMDT for touchONCOLOGY A medical oncologist, advanced practice nurse and patient advocate discuss possible side effects of colorectal cancer treatments and how they can be managed in the multidisciplinary team setting. The multidisciplinary team: Medical oncologist: Dr Kristen Ciombor, Vanderbilt University Medical Center, Nashville, TN, USA Advanced practice nurse: Dr Kelley Rone, Mayo Clinic...

touchMDT for touchONCOLOGY A medical oncologist, advanced practice nurse and patient advocate share their views on how the multidisciplinary team can support patients with HER2-positive colorectal cancer. The multidisciplinary team: Medical oncologist: Dr Kristen Ciombor, Vanderbilt University Medical Center, Nashville, TN, USA Advanced practice nurse: Dr Kelley Rone, Mayo Clinic, Phoenix, AZ, USA...

touchMDT for touchONCOLOGY Two medical oncologists discuss the latest clinical trial data for HER2-targeted treatments in colorectal cancer (CRC), how they utilize these agents in clinical practice, and what the future holds for HER2-targeting in CRC. The multidisciplinary team: Medical oncologists: Dr Kristen Ciombor, Nashville, TN, USA and Prof. Andrea Sartore-Bianchi, Milan, Italy This touchPOD...

touchPANEL DISCUSSION for touchONCOLOGY Listen to a panel of leading experts discuss the emerging role of antibody-drug conjugates (ADCs) in the treatment of patients with non-small cell lung cancer (NSCLC), including the mechanistic rationale and role of biomarkers in patient selection, the latest efficacy and safety data, and dose-finding strategies for optimal use in NSCLC.  The experts: Prof....

touchTALKS for touchONCOLOGY Listen to a leading expert in higher-risk myelodysplastic neoplasms (HR-MDS) discuss the impact that emerging treatment options may have on clinical practice. Dr David Sallman covers the latest updates to the classification of HR-MDS, the mode of action of emerging therapeutic agents and the most recent clinical evidence on their efficacy and safety. The expert: Dr Dav...

touchMDT for touchRESPIRATORY Listen to key experts from a multidisciplinary team and a patient advocate discuss how to optimize long-term outcomes for children with severe asthma.  The multidisciplinary team Paediatric immunologist: Dr Wanda Phipatanakul Primary care physician: Dr Ioanna Tsiligianni Specialist asthma nurse: Ms Viv Marsh Patient advocate: Ms Monique Cooper This touchPODCAST is for...

touchMDT for touchIMMUNOLOGY Listen to key experts from a multidisciplinary team and a patient advocate discuss how to optimize long-term outcomes for children with severe asthma.  The multidisciplinary team: Paediatric immunologist: Dr Wanda Phipatanakul, Boston Children’s Hospital, Harvard, MA, USA Primary care physician: Dr Ioanna Tsiligianni, University of Crete, Crete, Greece Specialist asthm...

touchMDT for touchRESPIRATORY Listen to key experts from a multidisciplinary team discuss strategies to monitor and support children with severe asthma. The multidisciplinary team Paediatric pulmonologist: Dr Atul Gupta, King’s College Hospital, London, UK Paediatric immunologist: Dr Wanda Phipatanakul, Boston Children’s Hospital, Harvard, MA, USA Primary care physician: Dr Ioanna Tsiligianni, Uni...